The Sanders Trust Enters 20th State, Acquires New $12M Facility in New York
Birmingham, Ala. – The Sanders Trust (TST), one of the nation’s leading healthcare real estate investment companies located in Birmingham, Ala., has acquired a new $12M cancer center located near Albany, N.Y. in Clifton Park. This property is the first New York acquisition for TST, which now has acquired or developed healthcare properties in 20 states.
“We are pleased that our organization continues its expansion throughout the U.S.,” said Rance Sanders, president and CEO of The Sanders Trust. “With renowned cancer care provider New York Oncology Hematology (NYOH) and the prestigious Albany Medical College offering patient services in the building, 3 Crossing Blvd will be a vital asset to the community.”
The almost 33,000-square foot facility was completed in April of this year and is situated approximately 16 miles north of downtown Albany. NYOH anchors the facility, and with 36 board-certified physicians and an oncology certified patient care team of over 300 personnel, is the region’s leading community-based cancer care service provider. Also represented in the building is Albany Medical College, one of the nation’s oldest private medical schools.
“This acquisition furthers TST’s investment strategy of adding $100 to $200 million each year to our portfolio by acquiring and developing strategic healthcare properties nationwide,” added Sanders.
About the Sanders Trust
The Sanders Trust develops and acquires medical office buildings, inpatient rehabilitation hospitals and specialty hospitals nationwide. Headquartered in Birmingham, Ala., The Sanders Trust (www.sanderstrust.com) has been a recognized leader in the investment community for healthcare clients since its inception in 1989 and has developed or acquired more than 60 medical properties in 20 states.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
